Navigation Links
Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
Date:9/17/2008

WALTHAM, Mass., Sept. 17 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the 2008 UBS Global Life Sciences Conference on Wednesday, September 24, 2008 at 1:00 p.m. EDT at the Grand Hyatt Hotel, 455 Madison Avenue, New York, NY.

A live audio-webcast of the presentation will be available via Repligen's website at http://www.repligen.com and will be archived for 30 days following the presentation.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for diseases that affect the central nervous system. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, managem
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
2. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
3. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
4. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
5. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
6. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
7. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
8. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
9. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
10. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
11. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 US-Australian drug discovery company, ... confirmed it is committed to progressing its ground-breaking technology ... practicable and to ensure the Company delivers the best ... Iain Ross , said the Company currently had ... pre-clinical programs, discovery programs and academic partnerships and initiatives, ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
... biologically safer water through point-of-use ... ultrafiltration, ... ),a medical device company, announced today that it will be exhibiting ... Conference and Technical Exhibition in National Harbor,Maryland, July 20th-23rd, 2008. Building ...
... Revenues While Advancing Three Major Clinical Programs, and Securing ... ... Million -, TUSTIN, Calif., July 14 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... ended April 30, 2008. Total revenues for FY 2008,increased 64% to ...
... Raptor,Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today ... to the Company,s board of,directors and Stephen C. ... (Photo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO ), Christopher M. ... stated, "I would like to welcome Drs. Franklin ...
Cached Biology Technology:Nephros Exhibiting at Maryland Ashe Conference July 20th-23rd 2Nephros Exhibiting at Maryland Ashe Conference July 20th-23rd 3Nephros Exhibiting at Maryland Ashe Conference July 20th-23rd 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 2Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 3Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 4Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 5Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 6Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 7Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 8Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 9Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 10Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 11Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board 2Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board 3Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board 4Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board 5
(Date:7/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ... "Global Outlook of the Biometrics Industry 2015 " ... The global biometrics market is likely to witness ... owing to the uptake of multiple technologies available. ... enhances the growth of biometrics in existing applications ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new ... fully hardware encapsulated fingerprint sensor and matching ... is literally off the grid, isolating fingerprint ... within the fingerprint sensor to provide ultimate ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... A major asthma discovery by a researcher at the ... licensed by MedImmune, a leading innovation-focused biotechnology company and ... the discovery to explore its use in the development ... Under the agreement, MedImmune was granted ...
... The availability of healthy food choices and your quality ... to two studies conducted by researchers at the Johns ... food availability and diet quality among Baltimore City and ... healthy foods was associated with quality of diet and ...
... Cutting edge science has finally put to rest a ... long-romanticized story of a child,s escape from the firing ... Medical School in cooperation with Institutions of ... Sciences (MHRC) have confirmed that human remains found ...
Cached Biology News:La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery 2La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery 3Healthy food availability could depend on where you live -- so does the quality of your diet 2Healthy food availability could depend on where you live -- so does the quality of your diet 3UMMS researchers publish DNA identification of czar's children 2UMMS researchers publish DNA identification of czar's children 3UMMS researchers publish DNA identification of czar's children 4
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood CD8+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: